KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Liabilities and Shareholders Equity: 2009-2025

Historic Liabilities and Shareholders Equity for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $26.8 billion.

  • Bausch Health Companies' Liabilities and Shareholders Equity rose 1.07% to $26.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $107.0 billion, marking a year-over-year decrease of 0.25%. This contributed to the annual value of $26.5 billion for FY2024, which is 3.02% down from last year.
  • Latest data reveals that Bausch Health Companies reported Liabilities and Shareholders Equity of $26.8 billion as of Q3 2025, which was down 1.62% from $27.3 billion recorded in Q2 2025.
  • Bausch Health Companies' 5-year Liabilities and Shareholders Equity high stood at $30.2 billion for Q1 2021, and its period low was $25.4 billion during Q1 2023.
  • In the last 3 years, Bausch Health Companies' Liabilities and Shareholders Equity had a median value of $26.5 billion in 2024 and averaged $26.6 billion.
  • Per our database at Business Quant, Bausch Health Companies' Liabilities and Shareholders Equity spiked by 77,328.21% in 2021 and then fell by 12.53% in 2023.
  • Over the past 5 years, Bausch Health Companies' Liabilities and Shareholders Equity (Quarterly) stood at $29.2 billion in 2021, then declined by 12.04% to $25.7 billion in 2022, then climbed by 6.48% to $27.4 billion in 2023, then declined by 3.02% to $26.5 billion in 2024, then grew by 1.07% to $26.8 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $26.8 billion for Q3 2025, versus $27.3 billion for Q2 2025 and $26.4 billion for Q1 2025.